Main Navigation
Mercia
Ventures
Debt
Private equity
Team
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
Audience
|
Change
Ventures
Debt
Private equity
Team
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Ventures
Debt
Private equity
Team
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Internal Fixation Systems Enters Into a Distribution Agreement With Intelligent Orthopaedics
Mercia EIS Funds | 10th May, 2012
Internal Fixation Systems Enters Into a Distribution Agreement With Intelligent Orthopaedics
Mercia EIS Funds | 18th April, 2012
NewNet Investor Profile of Andrew Oldfield Head of Clean Tech at Mercia Fund Management
Mercia EIS Funds | 17th March, 2012
Mercia Fund Management interview with AltAssets
Mercia EIS Funds | 7th March, 2012
STORM from Intelligent Orthopaedics Shown to Reduce Radiation Exposure during tibial fractures surgery
Mercia EIS Funds | 4th March, 2012
EIS schemes in 2012 – what you need to know
Mercia EIS Funds | 1st February, 2012
Smart Antenna Technologies BBC interview
Mercia EIS Funds | 2nd January, 2012
EIS Magazine launches
News | 1st January, 1970
UK medtech company, IBEX, demonstrates the clinical effectiveness of a radical new product
News | 1st January, 1970
WEBINAR: What ESG adds to Mercia’s EIS Funds
News | 1st January, 1970
WEBINAR: OXGENE – An outstanding exit for EIS investors
1
…
129
130
131
132
133
134
135
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...